Aidence rallies an international team of data scientists, medical and regulatory professionals, and software engineers to create AI applications for the oncology pathway. Their mission is to solve pressing clinical challenges by building and deploying AI solutions that seamlessly integrate into the clinical workflow, ensuring speed, accuracy, and ease of use.  

Aidence’s first clinical application is Veye Chest, an AI-based assistant for lung nodules on chest CT. Veye Chest is CE certified and currently running in clinical practice and lung cancer screening sites across Europe and the UK.  

Aidence was founded in Amsterdam in November 2015 by Mark-Jan Harte (CEO) and Jeroen van Duffelen (COO).